Cervical Intraepithelial Neoplasia Clinical Trials

A listing of Cervical Intraepithelial Neoplasia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
Featured trial
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)

A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)

  • 974 views
  • 08 Nov, 2020
  • 1 location
A Study of CIN-107 in Patients With Uncontrolled Hypertension (HALO)

This is a Phase 2, randomized, multicenter study to evaluate the efficacy and safety of multiple dose strengths of CIN-107 in the treatment of patients with uncontrolled hypertension.

  • 2 views
  • 11 Jul, 2022
  • 62 locations
Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries (DELTA)

This project develops, tests and produces a lightweight, cordless, battery driven and rechargeable hand-held device for treating cervical precancer (Liger Thermal Coagulator). The study evaluates its effectiveness compared to the current standard treatment (cryocautery) when used as part of a screen and treat programme using Visual Inspection with Acetic acid …

cervical cancer screening
cancer screening
loop electrosurgical excision
cancer
  • 2 views
  • 12 Feb, 2022
  • 1 location
Virtual Reality During Conization of Cervix Uterus Under Local Anesthesia

To evaluate the effectiveness of virtual reality glasses as a distraction technique in the management of acute pain and anxiety during conization of cervix uterus under local anesthesia

cone biopsy
anesthesia
  • 0 views
  • 13 Jun, 2022
  • 1 location
Phase I Norovirus Challenge Model

. Study duration is approximately 12-18 months with subject participation duration of 6-8 months. The primary objective of this study is to determine the optimal challenge dose of Norovirus GII.4 CIN-3

Accepts healthy volunteers
  • 0 views
  • 25 Jul, 2022
  • 1 location
Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

cryotherapy for the treatment of cervical precancer. The investigators will investigate whether the cure rates of cervical intraepithelial neoplasia 2 and more severe diagnoses (CIN2+) with these devices are

cervical intraepithelial neoplasia grade 2
cervical dysplasia
cin 3
cryotherapy
cervical high grade squamous intraepithelial lesion
  • 0 views
  • 27 Jul, 2022
  • 3 locations
Low-cost Imaging Technology for Global Prevention of Cervical Cancer

Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent …

cancer
colposcopy
dysplasia
prevention of cervical cancer
  • 0 views
  • 23 Oct, 2021
  • 2 locations
Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years

This phase 3 study will evaluate the immunogenicity and safety of Quadrivalent HPV recombinant vaccine in Chinese females aged 9 to 26 years

recombinant vaccine
lab tests
Accepts healthy volunteers
hpv vaccine
  • 0 views
  • 10 Mar, 2022
  • 1 location
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years

This phase 3 study will evaluate the immunogenicity and safety of 9-valent HPV recombinant vaccine in Chinese females aged 9 to 45 years

recombinant vaccine
human papilloma virus vaccine
hpv vaccine
Accepts healthy volunteers
lab tests
  • 2 views
  • 07 Mar, 2022
  • 1 location
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

This study is designed to evaluate the vaccine efficacy, immunogenicity and safety of the 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) in Chinese Female Subjects Aged 20-45 Years .

human papilloma virus vaccine
hpv vaccine
cancer
primary cancer
recombinant vaccine
  • 85 views
  • 13 Mar, 2022
  • 1 location